Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C2orf67 |
| Upstream (Parents) |
|---|
| (<<) NFIC → C2orf67 |
| (<<) BCL6 → C2orf67 |
| (<<) ARHGAP29 → C2orf67 |
| (<<) BTD → C2orf67 |
| (<<) MIA3 → C2orf67 |
| Downstream (Children) |
|---|
| C2orf67 → KSR1 (>>) |
| C2orf67 → EXOSC1 (>>) |
| C2orf67 → BRD8 (>>) |
| C2orf67 → MAGEA9B///MAGEA9 (>>) |
| C2orf67 → CCDC30 (>>) |
| C2orf67 → SBF1 (>>) |
| C2orf67 → SRY (>>) |
| C2orf67 → GJA8 (>>) |
| C2orf67 → AGFG2 (>>) |
| C2orf67 → ARL17A (>>) |
| C2orf67 → SMEK1 (>>) |
| C2orf67 → BCL6 (>>) |
| C2orf67 → SIX5 (>>) |
| C2orf67 → MED28 (>>) |
| C2orf67 → FAM108B1 (>>) |
| C2orf67 → HNMT (>>) |
| C2orf67 → ZNF254 (>>) |
| C2orf67 → RFX3 (>>) |
